NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, Forecast & News

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA announced a quarterly dividend on Friday, December 13th. Investors of record on Friday, December 27th will be given a dividend of $0.10 per share on Friday, January 10th. This represents a $0.40 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, December 26th. View DENTSPLY SIRONA's Dividend History.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) issued its quarterly earnings data on Thursday, November, 7th. The medical instruments supplier reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.07. The medical instruments supplier earned $962.10 million during the quarter, compared to analysts' expectations of $940.38 million. DENTSPLY SIRONA had a net margin of 4.08% and a return on equity of 10.08%. The business's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.38 EPS. View DENTSPLY SIRONA's Earnings History.

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for DENTSPLY SIRONA.

DENTSPLY SIRONA updated its FY19 earnings guidance on Thursday, November, 7th. The company provided earnings per share (EPS) guidance of $2.42-2.48 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.39. The company issued revenue guidance of $3.95-4.05 billion, compared to the consensus revenue estimate of $3.99 billion.

10 brokers have issued 12-month price targets for DENTSPLY SIRONA's shares. Their forecasts range from $50.00 to $65.00. On average, they expect DENTSPLY SIRONA's share price to reach $58.08 in the next twelve months. This suggests that the stock has a possible downside of 3.1%. View Analyst Price Targets for DENTSPLY SIRONA.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for DENTSPLY SIRONA.

News stories about XRAY stock have been trending somewhat positive this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for DENTSPLY SIRONA.

DENTSPLY SIRONA saw a decrease in short interest in December. As of December 31st, there was short interest totalling 3,540,000 shares, a decrease of 17.1% from the December 15th total of 4,270,000 shares. Based on an average daily trading volume, of 1,320,000 shares, the short-interest ratio is currently 2.7 days. Approximately 1.6% of the company's stock are sold short. View DENTSPLY SIRONA's Current Options Chain.

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), Cooper Companies (COO), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), QUALCOMM (QCOM), Starbucks (SBUX), Amgen (AMGN), Costco Wholesale (COST), Boeing (BA), General Electric (GE) and Analog Devices (ADI).

DENTSPLY SIRONA's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.24%), Commerzbank Aktiengesellschaft FI (0.09%), State of Alaska Department of Revenue (0.06%), Tocqueville Asset Management L.P. (0.05%), Clean Yield Group (0.05%) and Stonebridge Capital Management Inc. (0.04%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos and William E Newell. View Institutional Ownership Trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clean Yield Group, IFM Investors Pty Ltd, M&R Capital Management Inc., Welch & Forbes LLC, Tributary Capital Management LLC and Gateway Investment Advisers LLC. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell. View Insider Buying and Selling for DENTSPLY SIRONA.

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Tocqueville Asset Management L.P., Boston Trust Walden Corp, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, Courier Capital LLC and First Hawaiian Bank. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Gregory T Lucier and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $59.96.

DENTSPLY SIRONA has a market capitalization of $13.34 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,011,000,000.00 in net income (profit) each year or $2.01 on an earnings per share basis. DENTSPLY SIRONA employs 16,400 workers across the globe.View Additional Information About DENTSPLY SIRONA.

The official website for DENTSPLY SIRONA is http://www.dentsplysirona.com/.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]